Related Experiment Video
Updated: Sep 27, 2026

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
Published on: May 22, 2026
Hantavirus
1University of Texas at San Antonio, San Antonio, TX, USA.
Abstract:
Sin Nombre virus (SNV), an emerging pathogen in the United States, was identified in 1993. This hantavirus, a member of the Bunyaviridae family of RNA viruses, is transmitted by its reservoir host Peromyscus maniculatus, the deer mouse. Transmission is by inhalation of aerosolized feces, urine, or saliva from the infected mice. The illness that pursues, hantavirus pulmonary syndrome (HPS), is characterized initially by mild flu-like symptoms, followed by rapid progression to respiratory distress. There is no established therapeutic regimen and treatment is only supportive. Preventive methods include attempts to minimize contact with the rodents since elimination of the virus is not realistic.
Insights
Sin Nombre virus (SNV), a hantavirus emerging in the US, is transmitted by deer mice via aerosolized particles. Hantavirus pulmonary syndrome (HPS) causes flu-like symptoms and severe respiratory distress, with supportive care as the only treatment.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Sin Nombre virus (SNV), identified in 1993, is an emerging hantavirus in the United States.
- SNV belongs to the Bunyaviridae family of RNA viruses.
- The deer mouse (Peromyscus maniculatus) is the primary reservoir host.
Purpose of the Study:
- To summarize the transmission, clinical presentation, and management of Sin Nombre virus and hantavirus pulmonary syndrome.
Main Methods:
- Literature review of SNV and hantavirus pulmonary syndrome (HPS).
- Analysis of transmission routes and clinical characteristics.
- Review of current treatment and prevention strategies.
Main Results:
- SNV is transmitted through inhalation of aerosolized excreta from infected deer mice.
- Hantavirus pulmonary syndrome (HPS) presents initially with flu-like symptoms, rapidly progressing to respiratory distress.
- No specific antiviral therapy exists; treatment is supportive.
Conclusions:
- Minimizing contact with rodents is crucial for preventing SNV infection.
- Effective elimination of the virus from the environment is not feasible.
- Continued research and public health awareness are essential for managing SNV and HPS.
Related Concept Videos
Rabies
Respiratory Syncytial Virus Disease
Hepatitis
Arboviral Encephalitis
Poliomyelitis
Viral Hepatitis I: Introduction

